Video | July 23, 2026

Which Discovery Technologies Help Solve Degrader Assay Gaps

Source: Drug Discovery Online

Johannes Yeh says degrader discovery requires robust screening systems to measure target engagement, ternary complex formation, stability, and degradation, supported by tools such as CRISPR, shRNA, and proteomics. Maria Soloveychik adds that her company built a cell-based platform to test induced proximity and degradation intracellularly, using viability as a functional readout before confirming hits with biophysical assays, genomics, mutagenesis, and SAR.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online